![Marc Blaustein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Blaustein
Geen lopende functies
Profiel
Marc B. Blaustein is the founder of Akashi Therapeutics Inc, which was founded in 2011.
He held the title of Chief Executive Officer from 2011 to 2017.
Mr. Blaustein's former jobs include being the Chief Executive Officer of Ned Biosystems, Inc. from 2017 to 2019, Head of Business Development at Genetics Institute LLC, Senior Vice President of Manufacturing, Process & Commercial Operations at Dyax Corp.
from 2006 to 2009, Chief Operating, Financial & Accounting Officer at Finch Therapeutics Group, Inc. from 2022 to 2023, and Head of Business Development at Guide Therapeutics, Inc. from 2019 to 2021.
He is also a Founding Partner at Northbridge Consulting.
Mr. Blaustein's education includes a graduate degree from Harvard University and an undergraduate degree from the University of Pennsylvania.
Eerdere bekende functies van Marc Blaustein
| Bedrijven | Functie | Einde |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Financieel Directeur/CFO | 15-05-2023 |
Guide Therapeutics, Inc.
 Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Corporate Officer/Principal | 01-01-2021 |
Ned Biosystems, Inc.
 Ned Biosystems, Inc. BiotechnologyHealth Technology Develops proprietary combination cancer therapies | Algemeen Directeur | 01-01-2019 |
Akashi Therapeutics Inc
 Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Algemeen Directeur | 01-01-2017 |
| DYAX CORP. | Corporate Officer/Principal | 01-01-2009 |
Opleiding van Marc Blaustein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akashi Therapeutics Inc
Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Ned Biosystems, Inc.
Ned Biosystems, Inc. BiotechnologyHealth Technology Develops proprietary combination cancer therapies | Health Technology |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Guide Therapeutics, Inc.
Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Health Technology |
Northbridge Consulting |
